Lung Cancer
Conference Coverage
Lung cancer screening pushes 20-year survival rate to 80%
Less than 6% of high-risk smokers get the recommended annual lung cancer screening.
News
Buzz kill: Lung damage looks worse in pot smokers
Emphysema was significantly more common among smokers (75%) than among nonsmokers, a new study finds.
News
Chronic stress, especially race related, may hasten cancer death
High allostatic load was associated with an 80% increased risk of cancer death among all study participants.
News
Third COVID booster benefits cancer patients
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.
News
Durvalumab combinations show tentative promise in NSCLC
Phase 2 study indicates improved survival and objective response rate when combined with other immunotherapies.
Opinion
Had my patient come in today, we may have had other options
FDA’s approval of trastuzumab deruxtecan is a game-changer for NSCLC patients with HER alterations.
News
Despite benefits, extended-interval pembro uptake remains low
It’s possible that low uptake could stem from clinicians’ doubts about switching to an extended-interval dose, given that the FDA’s approval was...
Conference Coverage
Weight gain linked to cancer survival in men and women
The finding underscores the need for nutritional support emphasized in 2020 ASCO guidelines.
Conference Coverage
High BMI linked to better survival for cancer patients treated with ICI, but for men only
The reasons behind the findings and implications for treatment are unknown, as is whether it applies to patients with specific cancers.
Latest News
Atezolizumab doubles survival of NSCLC patients with poor performance status
Patients typically excluded from clinical trials because of age or comorbidities had better survival with atezolizumab than single-agent...